Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Auxilium says FDA approved hand drug Xiaflex
Yahoo/AP
Wednesday, February 3, 2010 - 9:30am
tags:
FDA, Auxilium, Xiaflex
Pfizer In-Line, Guidance Down
Yahoo/Zacks.com
Wednesday, February 3, 2010 - 9:29am
tags:
Pfizer, earnings, guidance
Roche Second-Half Profit Rises on Genentech Savings
Bloomberg
Wednesday, February 3, 2010 - 7:47am
tags:
Roche, Genentech, earnings
Pfizer profit more than doubles
Marketwatch
Wednesday, February 3, 2010 - 7:46am
tags:
Pfizer, earnings
Takeda Profit Falls on Cost to Buy Experimental Drugs
Bloomberg
Wednesday, February 3, 2010 - 6:47am
tags:
Takeda, earnings
FDA takes up Javelin drug for review
Bizjournals.com
Wednesday, February 3, 2010 - 6:45am
tags:
FDA, Javelin, NSAIDs, Dyloject
Former Wyeth CEO: Pharma Chiefs Face ‘More Punishing’ Environment
WSJ Online
Tuesday, February 2, 2010 - 7:44pm
tags:
Pharma CEOs, Wyeth
Shaking Up the Biotech Industry
Motley Fool
Tuesday, February 2, 2010 - 6:28pm
tags:
personalized medicine, DNA, Myriad Genetics
Glaxo CEO: Time to diversify, help poor countries
Yahoo/AP
Tuesday, February 2, 2010 - 5:16pm
tags:
GSK, Pharma CEOs, Andrew Witty, diversification
Fourth Quarter Trends for Big Pharma
Seeking Alpha
Tuesday, February 2, 2010 - 5:13pm
tags:
Abbott Laboratories, AstraZeneca, Sanofi, Merck, GSK, Pfizer
Eli Lilly and the Depression-Diabetes Circle
Minyanville
Tuesday, February 2, 2010 - 5:12pm
tags:
depression, diabetes, Zyprexa, Eli Lilly
Drug stocks hug flat line; Warner Chilcott climbs
Marketwatch
Tuesday, February 2, 2010 - 11:12am
tags:
drug stocks, Warner Chilcott
Pfizer Moves Toward Goal of Becoming Top-Tier Biotherapeutics Company
Seeking Alpha
Tuesday, February 2, 2010 - 11:11am
tags:
Pfizer
GlaxoSmithKline's Malaria Database Deserves More Press
Seeking Alpha
Tuesday, February 2, 2010 - 11:10am
tags:
GSK, malaria
Medivation's Alzheimer Trial Data in Early March
TheStreet.com
Tuesday, February 2, 2010 - 11:09am
tags:
Alzheimer's disease, drug trials, Medivation, Pfizer, dimebon
Cephalon Discloses Payments To Doctors
Pharmalot
Tuesday, February 2, 2010 - 10:53am
tags:
physician payments, Cephalon
Mystery Alzheimer’s Drug May Yield Advance for Pfizer
Bloomberg
Tuesday, February 2, 2010 - 10:27am
tags:
Pfizer, Alzheimer's disease, dimebon
Lilly Learns a Lesson on Cialis: Price Hikes Work
BNET Pharma
Tuesday, February 2, 2010 - 10:16am
tags:
Eli Lilly, drug pricing, Cialis
Protalix shares dip as FDA poses new Gaucher drug query
Fierce Biotech
Tuesday, February 2, 2010 - 10:05am
tags:
Gaucher disease, Protalix BioTherapeutics, FDA
Roche Filed Most Domain Arbitration Cases In ‘09
Pharmalot
Tuesday, February 2, 2010 - 10:03am
tags:
Roche

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.